by TMR / pic by TMR FILE
MSM Prai Bhd, a wholly owned subsidiary of MSM Malaysia Holdings Bhd, resumed its operation after being suspended on June 8 due to Covid-19 infection.
In a statement yesterday, the sugar refiner said it has adhered to the standard operating procedures and guidelines as outlined by the authorities for the industrial sector.
The estimated impact of the temporary suspension based on the initial assessment to the company’s revenue and earnings is less than 5% for the financial year ending Dec 31, 2021.
Initially, MSM Prai was ordered to temporarily suspend its operation from June 8, 2021, until June 17, 2021, by the Ministry of Health for the disinfection of the affected premises in curbing the spread of Covid-19.
“MSM Prai will recommence its refinery operations in stages. However, barring any unprecedented setback to the operations, MSM Prai is expected to promptly regain its production momentum in view of the refinery’s reliable performance and consistent production capabilities,” said MSM group CEO Syed Feizal Syed Mohammad.
It added that it will continue to monitor the operational progress while ensuring stringent preventive measures are being enforced to address the health, safety and wellbeing of its employees.
MSM has also applied for a priority request on the vaccination programme to be carried out for all employees under the group following MSM being considered one of the essential food producers,” said Syed Feizal.
The company is also actively pursuing to claim the losses incurred during the suspension from the insurer.
The group has also placed in mitigation plans to ward off stock shortage and minimise the supply chain disruption through recalibration of its business continuity strategy and by utilising the allowance of permit to import refined sugar.
MSM Prai’s production capacity remains 1.05 million tonnes per annum and is set to ramp up its production to reach the targeted utilisation rate for the year.
Previously, all 756 employees at the premises including the contract workers had undergone testing over a two-day screening period as a proactive measure.